These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm. Lee S; Park S; Lew H Korean J Ophthalmol; 2018 Feb; 32(1):1-7. PubMed ID: 29376224 [TBL] [Abstract][Full Text] [Related]
24. Blepharospasm: long-term treatment with either Botox®, Xeomin® or Dysport®. Kollewe K; Mohammadi B; Köhler S; Pickenbrock H; Dengler R; Dressler D J Neural Transm (Vienna); 2015 Mar; 122(3):427-31. PubMed ID: 25059456 [TBL] [Abstract][Full Text] [Related]
25. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment. Quagliato EM; Carelli EF; Viana MA Clin Neuropharmacol; 2010; 33(1):27-31. PubMed ID: 20124784 [TBL] [Abstract][Full Text] [Related]
26. Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy. Lungu C; Considine E; Zahir S; Ponsati B; Arrastia S; Hallett M Eur J Neurol; 2013 Mar; 20(3):515-518. PubMed ID: 23146065 [TBL] [Abstract][Full Text] [Related]
27. Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs. Bentivoglio AR; Fasano A; Ialongo T; Soleti F; Lo Fermo S; Albanese A Neurotox Res; 2009 Apr; 15(3):224-31. PubMed ID: 19384595 [TBL] [Abstract][Full Text] [Related]
28. Re: "Comparison of preferences between onabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm". Giacometti J; Yen MT Ophthalmic Plast Reconstr Surg; 2014; 30(1):76-7. PubMed ID: 24398499 [No Abstract] [Full Text] [Related]
29. Reply Re: "Comparison of preferences between onabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm". Chundury RV; Couch SM; Holds JB Ophthalmic Plast Reconstr Surg; 2014; 30(1):77. PubMed ID: 24398500 [No Abstract] [Full Text] [Related]
30. Comparison of Safety and Efficacy of Botox and Neuronox in the Management of Benign Essential Blepharospasm: A Split-face Study. Sane S; Ali MJ; Naik MN Korean J Ophthalmol; 2019 Oct; 33(5):430-435. PubMed ID: 31612653 [TBL] [Abstract][Full Text] [Related]
31. Impact of botulinum toxin injections on quality of life and self-esteem in patients with blepharospasm. Tang M; Li W; Ji F; Li X; Zhang Y; Liu P Psychol Health Med; 2019 Jun; 24(5):513-518. PubMed ID: 30463432 [TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin type A therapy for blepharospasm. Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C Cochrane Database Syst Rev; 2005 Jan; (1):CD004900. PubMed ID: 15674969 [TBL] [Abstract][Full Text] [Related]
33. A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm. Rieder CR; Schestatsky P; Socal MP; Monte TL; Fricke D; Costa J; Picon PD Clin Neuropharmacol; 2007; 30(1):39-42. PubMed ID: 17272968 [TBL] [Abstract][Full Text] [Related]
34. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm. Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711 [TBL] [Abstract][Full Text] [Related]
35. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results. Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788 [TBL] [Abstract][Full Text] [Related]
36. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm. Park DI; Shin HM; Lee SY; Lew H Acta Ophthalmol; 2013 Mar; 91(2):e108-12. PubMed ID: 23425111 [TBL] [Abstract][Full Text] [Related]
38. Relations between nonmotor manifestations and motor disorders in patients with benign essential blepharospasm. Zhou Y; Wang W; Lin Z; Lin T; Gong L Graefes Arch Clin Exp Ophthalmol; 2023 Dec; 261(12):3615-3623. PubMed ID: 37341835 [TBL] [Abstract][Full Text] [Related]
39. The long-term response to botulinum toxin injections in patients with blepharospasm undergoing upper eyelid surgery. Trinchillo A; Cuomo N; Habetswallner F; Esposito M Parkinsonism Relat Disord; 2024 Feb; 119():105958. PubMed ID: 38118281 [TBL] [Abstract][Full Text] [Related]
40. Switch from abobotulinumtoxinA (Dysport®) to incobotulinumtoxinA (Xeomin®) botulinum toxin formulation: a review of 257 cases. Grosset DG; Tyrrell EG; Grosset KA J Rehabil Med; 2015 Feb; 47(2):183-6. PubMed ID: 25325305 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]